ValiRx Plc

Type: Company
Name: ValiRx Plc
First reported Jun 24 2014 - Updated Jun 24 2014 - 1 reports

Director Deals - ValiRx PLC (VAL)

StockMarketWire.com - Kevin Alexander, Non Executive Director, bought 1,612,903 shares in the company on the 23rd June 2014 at a price of 0.31p. The Director now holds 8,034,843 shares. Story provided by StockMarketWire.com Director deals data provided ... [Published Stock Market Wire - Jun 24 2014]
Entities: ValiRx Plc
First reported Jun 24 2014 - Updated Jun 24 2014 - 3 reports

New Corporate Website & New Office Address

("ValiRx" or "the Company")ValiRx Plc (AIM: VAL), the life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, is pleased to announce the launch of its newly designed corporate website and to advise on the Company's ... [Published Noodls - Jun 24 2014]
First reported Jun 10 2014 - Updated Jun 10 2014 - 1 reports

Broker spotlight: Stagecoach, ASOS, Sports Direct, First Quantum, ValiRx ...

You wait ages for a broker note on buses and train operators and two turn up at once. Deutsche Bank expects this year to continue to be dominated by rail re-franchising awards.  So far this year Thameslink has been awarded to Govia (from FirstGroup ... [Published Proactiveinvestors United Kingdom website - Jun 10 2014]
First reported Jun 10 2014 - Updated Jun 10 2014 - 1 reports

ValiRx lead treatment moves to human stage cancer trial

ValiRx ( LON:VAL ) applied to the UK Medicines Agency for permission to carry out a phase I/II trial on VAL201, its lead cancer treatment.   The dose escalation study will assess the safety and tolerability of VAL201 in patients with locally advanced ... [Published Proactiveinvestors United Kingdom RSS feed - Jun 10 2014]
First reported May 15 2014 - Updated May 15 2014 - 2 reports

Proactive news summary: Antrim Energy, Caza, Fastjet, Galileo, Golden Saint, Kalibrate, Landore ...

Thursday was a day when Canadian listed and Canada-focused companies stormed the Proactive Investors universe. The recent strength in the nickel price is "fantastic" for Canada-focused mining firm Landore Resources ( LON:LND ), says its chief executive. ... [Published Proactiveinvestors United Kingdom RSS feed - May 15 2014]
First reported May 15 2014 - Updated May 15 2014 - 1 reports

ValiRx pleased with new joint venture's early progress

ValiRx’s (LON:VAL) new joint venture, Valiseek, has made an encouraging start with its lung cancer treatment being well tolerated in early stage studies, the drug development company said today.Valiseek was set up in April to speed the progres...Related ... [Published BioPortfolio - May 15 2014]
First reported May 01 2014 - Updated May 01 2014 - 2 reports

ValiRx gets Japanese patent approval for NAV3 biomarker

ValiRx’s (LON:VAL) NAV3, a cancer screening test gene biomarker has recently received patent approval from the Japanese patent office (JPO).The granting of this latest patent means that ValiRx now has biomarker granted patent protection in Jap...Related ... [Published BioPortfolio - May 01 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 2 reports

Proactive news summary: InternetQ, AdEPT Telecom, ValiRx, Ncondezi Energy, Gemfields, ANGLE

Mobile marketing specialist InternetQ ( LON:INTQ ) had its target price hiked by Canaccord Genuity on Tuesday after impressive full-year figures. Adjusted EBITDA rose by a third to €16.2mln in 2013 from €12.2mln the year before on the back of a 42% ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 5 reports

UPDATE ValiRx sets up joint venture to advance lung cancer drug

---adds broker comment and share price---ValiRx (LON:VAL) has set up a joint venture firm with Tangent Reprofiling to advance a treatment for lung cancer, for which the market is valued at around US$5 billion.ValiSeek has purchased the exclusive wo.. ... [Published BioPortfolio - Apr 08 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 2 reports

Most followed: AFC Energy, Advanced Comp, Barclays, Falkland Islands, Motive TV, Quindell, ValiRx

Aside from the latest twist in the LIBOR saga involving Barclays ( LON:BARC ), news on the blue-chips is sparse today. That leaves the stage open for the growth stocks, and one of the hottest stories of the morning has been the joint venture announced ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 2 reports

Q&A ValiRx looks forward to clinical trials

Related Biotechnology, Pharmaceutical and Healthcare NewsProactive Investors (PI) interviewed the management of the cancer drug treatment developer to find out about future plans.Original Article: Q&A: ValiRx looks forward to clinical trialsNEXT ARTICLE ... [Published BioPortfolio - Apr 01 2014]
First reported Feb 20 2014 - Updated Feb 20 2014 - 2 reports

ValirX gets new European grant for cancer screening biomarker

ValiRx (LON:VAL) has received European patent approval for its cancer screening test biomarker NAV3.The test enables cancer cells to be detected in tissue samples at a stage where tumour development is only about to start.The system can be used in...Related ... [Published BioPortfolio - Feb 20 2014]

Quotes

Dr Satu Vainikka, ValiRx ’s chief executive, said:   "We are delighted that the team have taken the VAL201 clinical trial programme to the human trial stage, but importantly, have taken the study beyond what was originally envisaged and onto the threshold of Phase II."
Landore chief executive Richard Prickett told Proactive: "We were actually going to make money at US$14,000 a tonne so this is just all on top of that and really fantastic."
"The granting of this latest patent by the JPO shortly after our European patent grant, not only further extends our global geographic patent coverage, but continues to endorse the Board's decision to establish ValiFinn and our Finnish biomarkers business, in an increasingly fast growing marketplace" said Dr Satu Vainikka, chief executive officer of ValiRx
NEXT ARTICLE More From BioPortfolio on "UPDATE - ValiRx sets up joint venture to advance lung cancercancer drug"

More Content

All (45) | News (42) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Prostate Cancer - Pipeline Review, H1 2014 - Ne... [Published SBWire - Jul 14 2014]
Director Deals - ValiRx PLC (VAL) [Published Stock Market Wire - Jun 24 2014]
New Corporate Website & New Office Address [Published Noodls - Jun 24 2014]
ValiRx : New Corporate Website & New Office Add... [Published 4 Traders - Jun 24 2014]
ValiRx PLC : Director/PDMR Shareholding [Published Investegate - Jun 24 2014]
Broker spotlight: Stagecoach, ASOS, Sports Dire... [Published Proactiveinvestors United Kingdom website - Jun 10 2014]
ValiRx lead treatment moves to human stage canc... [Published Proactiveinvestors United Kingdom RSS feed - Jun 10 2014]
Proactive news summary: Antrim Energy, Caza, Fa... [Published Proactiveinvestors United Kingdom RSS feed - May 15 2014]
US equities continue their slide [Published Proactiveinvestors United Kingdom RSS feed - May 15 2014]
ValiRx pleased with new joint venture's early p... [Published BioPortfolio - May 15 2014]
ValiRx gets Japanese patent approval for NAV3 b... [Published BioPortfolio - May 01 2014]
ValiRx gets Japanese patent approval for NAV3 b... [Published Proactiveinvestors United Kingdom RSS feed - May 01 2014]
Upgrade hints at ValiRx's significant potential [Published Proactiveinvestors United Kingdom RSS feed - Apr 14 2014]
Proactive news summary: InternetQ, AdEPT Teleco... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
UPDATE ValiRx sets up joint venture to advance... [Published BioPortfolio - Apr 08 2014]
UPDATE - ValiRx sets up joint venture to advanc... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
Most followed: AFC Energy, Advanced Comp, Barcl... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
UKs ValiRx forms joint venture to fast track lu... [Published BioPortfolio - Apr 08 2014]
Most followed: AFC Energy, Advanced Comp, Barcl... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
Innovation Forum [Published TrustNet - Apr 08 2014]
Market movers including Sports Direct, ValiRx, ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
ValiRx sets up joint venture to advance lung ca... [Published Proactiveinvestors United Kingdom website - Apr 08 2014]
ValiRx sets up joint venture to advance lung ca... [Published Proactiveinvestors United Kingdom RSS feed - Apr 08 2014]
ValiRx, e-Therapeutics, Oxford Pharmascience an... [Published Proactiveinvestors United Kingdom RSS feed - Apr 04 2014]
ValiRx, e-Therapeutics, Oxford Pharmascience an... [Published Proactiveinvestors United Kingdom RSS feed - Apr 04 2014]
ValiRx, e-Therapeutics, Oxford Pharmascience an... [Published Proactiveinvestors United Kingdom RSS feed - Apr 04 2014]
ValiRx, e-Therapeutics, Oxford Pharmascience an... [Published Proactiveinvestors United Kingdom RSS feed - Apr 04 2014]
Proactive news summary including Chaarat Gold, ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 01 2014]
Q&A ValiRx looks forward to clinical trials [Published BioPortfolio - Apr 01 2014]
Q&A: ValiRx looks forward to clinical trials [Published Proactiveinvestors United Kingdom RSS feed - Apr 01 2014]
1 2
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Broker spotlight: Stagecoach, ASOS, Sports Dire... [Published Proactiveinvestors United Kingdom website - Jun 10 2014]
You wait ages for a broker note on buses and train operators and two turn up at once. Deutsche Bank expects this year to continue to be dominated by rail re-franchising awards.  So far this year Thameslink has been awarded to Govia (from FirstGroup ...
ValiRx sets up joint venture to advance lung ca... [Published Proactiveinvestors United Kingdom website - Apr 08 2014]
ValiRx ( LON:VAL ) has set up a joint venture firm with Tangent Reprofiling Ltd to advance a treatment for lung cancer, for which the market is valued at around US$5 billion. ValiSeek has purchased the exclusive worldwide licence for the drug VAL401 ...
ValiRx says annual results show the company is ... [Published Proactiveinvestors United Kingdom website - Mar 26 2014]
George Morris, chief operating officer of ValiRx ( LON:VAL ) tells Proactiveinvestors the company's annual results show the company is 'making progress'. ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.